Diakonos Oncology Secures $20 Million Financing to Advance Dendritic Cell Cancer Immunotherapy
Diakonos Oncology, a clinical-stage biotechnology company based in Houston focused on developing next-generation immunotherapies for aggressive cancers, has continued to strengthen its financial position through…
